Aging causes morphological alterations in astrocytes and microglia in human substantia nigra pars compacta

Abe, 2010, Postnatal development of neurons, interneurons and glial cells in the substantia nigra of mice, Cell Mol. Neurobiol., 30, 917, 10.1007/s10571-010-9521-0 Ahmed, 2007, Actin-binding proteins coronin-1a and IBA-1 are effective microglial markers for immunohistochemistry, J. Histochem. Cytochem., 55, 687, 10.1369/jhc.6A7156.2007 Alladi, 2010, Expression of GDNF receptors GFRalpha1 and RET is preserved in substantia nigra pars compacta of aging Asian Indians, J. Chem. Neuroanat., 40, 43, 10.1016/j.jchemneu.2010.03.007 Alladi, 2010, Ageing enhances alpha-synuclein, ubiquitin and endoplasmic reticular stress protein expression in the nigral neurons of Asian Indians, Neurochem. Int., 57, 530, 10.1016/j.neuint.2010.06.018 Alladi, 2009, Absence of age-related changes in nigral dopaminergic neurons of Asian Indians: relevance to lower incidence of Parkinson's disease, Neuroscience, 159, 236, 10.1016/j.neuroscience.2008.11.051 Annese, 2013, Evidence of oligodendrogliosis in MPTP-induced Parkinsonism, Neuropathol. Appl. Neurobiol., 39, 132, 10.1111/j.1365-2990.2012.01271.x Banati, 1998, Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease, Mov. Disord., 13, 221, 10.1002/mds.870130205 Barcia, 2011, IFN-gamma signaling, with the synergistic contribution of TNF-alpha, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease, Cell Death Dis., 2, e142, 10.1038/cddis.2011.17 Barcia, 2009, Increase of secondary processes of microglial and astroglial cells after MPTP-induced degeneration in substantia nigra pars compacta of non human primates, J. Neural Transm. Suppl., 73, 253 Barres, 2008, The mystery and magic of glia: a perspective on their roles in health and disease, Neuron, 60, 430, 10.1016/j.neuron.2008.10.013 Beach, 2007, Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment deposits, Acta Neuropathol., 114, 419, 10.1007/s00401-007-0250-5 Bianchi, 2011, S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release, J. Biol. Chem., 286, 7214, 10.1074/jbc.M110.169342 Blaustein, 1996, The Na(+)-Ca2+ exchanger in rat brain synaptosomes. Kinetics and regulation, Ann. N. Y. Acad. Sci., 779, 300, 10.1111/j.1749-6632.1996.tb44803.x Branch, 2014, Aging decreases L-type calcium channel currents and pacemaker firing fidelity in substantia nigra dopamine neurons, J. Neurosci., 34, 9310, 10.1523/JNEUROSCI.4228-13.2014 Chu, 2002, Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra, J. Comp. Neurol., 450, 203, 10.1002/cne.10261 Collier, 2011, Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates, Nat. Rev. Neurosci., 12, 359, 10.1038/nrn3039 Damier, 1999, The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry, Brain, 122, 1421, 10.1093/brain/122.8.1421 Goss, 1991, Age-related changes in glial fibrillary acidic protein mRNA in the mouse brain, Neurobiol. Aging, 12, 165, 10.1016/0197-4580(91)90056-P Griffin, 1989, Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease, Proc. Natl. Acad. Sci. U. S. A., 86, 7611, 10.1073/pnas.86.19.7611 Halliday, 2005, Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease, Brain, 128, 2654, 10.1093/brain/awh584 Han, 2010, Analysis of neuronal nitric oxide synthase expression and increasing astrogliosis in the brain of senescence-accelerated-prone 8 mice, Int. J. Neurosci., 120, 602, 10.3109/00207454.2010.503911 Hirsch, 2003, The role of glial reaction and inflammation in Parkinson's disease, Ann. N. Y. Acad. Sci., 991, 214, 10.1111/j.1749-6632.2003.tb07478.x Hirsch, 2012, Neuroinflammation in Parkinson's disease, Parkinsonism Relat. Disord., 18, S210, 10.1016/S1353-8020(11)70065-7 Imamura, 2003, Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains, Acta Neuropathol., 106, 518, 10.1007/s00401-003-0766-2 Kanaan, 2008, Age and region-specific responses of microglia, but not astrocytes, suggest a role in selective vulnerability of dopamine neurons after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure in monkeys, Glia, 56, 1199, 10.1002/glia.20690 Kanaan, 2010, Age-related changes in glial cells of dopamine midbrain subregions in rhesus monkeys, Neurobiol. Aging, 31, 937, 10.1016/j.neurobiolaging.2008.07.006 Kim, 2013, Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia, Nat. Commun., 4, 1562, 10.1038/ncomms2534 Kim, 2005, Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia, J. Neurosci., 25, 3701, 10.1523/JNEUROSCI.4346-04.2005 Knott, 2000, Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2, Mol. Cell Neurosci., 16, 724, 10.1006/mcne.2000.0914 Kubis, 2000, Preservation of midbrain catecholaminergic neurons in very old human subjects, Brain, 123, 366, 10.1093/brain/123.2.366 Kurihara, 1967, The regional and subcellular distribution of 2',3'-cyclic nucleotide 3'-phosphohydrolase in the central nervous system, J. Neurochem., 14, 1167, 10.1111/j.1471-4159.1967.tb06164.x Langston, 1999, Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure, Ann. Neurol., 46, 598, 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F Lappe-Siefke, 2003, Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination, Nat. Genet., 33, 366, 10.1038/ng1095 Ma, 1999, Unbiased morphometrical measurements show loss of pigmented nigral neurones with ageing, Neuropathol. Appl. Neurobiol., 25, 394, 10.1046/j.1365-2990.1999.00202.x MacVicar, 1987, Morphological differentiation of cultured astrocytes is blocked by cadmium or cobalt, Brain Res., 420, 175, 10.1016/0006-8993(87)90256-3 McGeer, 2003, Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration, Ann. Neurol., 54, 599, 10.1002/ana.10728 Mena, 2002, The role of astroglia on the survival of dopamine neurons, Mol. Neurobiol., 25, 245, 10.1385/MN:25:3:245 Migheli, 1999, S-100beta protein is upregulated in astrocytes and motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis, Neurosci. Lett., 261, 25, 10.1016/S0304-3940(98)01001-5 Mirza, 2000, The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease, Neuroscience, 95, 425, 10.1016/S0306-4522(99)00455-8 Mrak, 1996, Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease, J. Neuropathol. Exp. Neurol., 55, 273, 10.1097/00005072-199603000-00002 Muramatsu, 2003, Expression of S-100 protein is related to neuronal damage in MPTP-treated mice, Glia, 42, 307, 10.1002/glia.10225 Muthane, 1998, Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India, Ann. Neurol., 43, 283, 10.1002/ana.410430304 Mythri, 2011, Evaluation of markers of oxidative stress, antioxidant function and astrocytic proliferation in the striatum and frontal cortex of Parkinson's disease brains, Neurochem. Res., 36, 1452, 10.1007/s11064-011-0471-9 Nakajima, 2001, GDNF is a major component of trophic activity in DA-depleted striatum for survival and neurite extension of DAergic neurons, Brain Res., 916, 76, 10.1016/S0006-8993(01)02866-9 Nguyen, 2013, Analysis of inflammation-related nigral degeneration and locomotor function in DJ-1(-/-) mice, J. Neuroinflammation, 10, 50, 10.1186/1742-2094-10-50 Nixon, 2003, The calpains in aging and aging-related diseases, Ageing Res. Rev., 2, 407, 10.1016/S1568-1637(03)00029-1 Peters, 2002, The effects of normal aging on myelin and nerve fibers: a review, J. Neurocytol., 31, 581, 10.1023/A:1025731309829 Rasband, 2005, CNP is required for maintenance of axon-glia interactions at nodes of Ranvier in the CNS, Glia, 50, 86, 10.1002/glia.20165 Sailaja, 1994, Developing substantia nigra in human: a qualitative study, Dev. Neurosci., 16, 44, 10.1159/000112087 Sathe, 2012, S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-alpha pathway, Brain, 135, 3336, 10.1093/brain/aws250 Schafer, 2012, Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner, Neuron, 74, 691, 10.1016/j.neuron.2012.03.026 Sheng, 1994, S100 beta protein expression in Alzheimer disease: potential role in the pathogenesis of neuritic plaques, J. Neurosci. Res., 39, 398, 10.1002/jnr.490390406 Sherer, 2003, Selective microglial activation in the rat rotenone model of Parkinson's disease, Neurosci. Lett., 341, 87, 10.1016/S0304-3940(03)00172-1 Siddiqi, 1999, The effect of aging on pars compacta of the substantia nigra in rhesus monkey, J. Neuropathol. Exp. Neurol., 58, 903, 10.1097/00005072-199909000-00002 Sloane, 2003, Age-dependent myelin degeneration and proteolysis of oligodendrocyte proteins is associated with the activation of calpain-1 in the rhesus monkey, J. Neurochem., 84, 157, 10.1046/j.1471-4159.2003.01541.x Thannickal, 2007, Hypocretin (orexin) cell loss in Parkinson's disease, Brain, 130, 1586, 10.1093/brain/awm097 Trapp, 1988, Cellular and subcellular distribution of 2',3'-cyclic nucleotide 3'-phosphodiesterase and its mRNA in the rat central nervous system, J. Neurochem., 51, 859, 10.1111/j.1471-4159.1988.tb01822.x Van Eldik, 1994, S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions, Biochim. Biophys. Acta, 1223, 398, 10.1016/0167-4889(94)90101-5 Weinstock, 2011, Ladostigil prevents age-related glial activation and spatial memory deficits in rats, Neurobiol. Aging, 32, 1069, 10.1016/j.neurobiolaging.2009.06.004 Wilms, 2003, Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease, FASEB J., 17, 500, 10.1096/fj.02-0314fje Zanotti, 1997, Extracellular calcium sensing by glial cells: low extracellular calcium induces intracellular calcium release and intercellular signaling, J. Neurochem., 69, 594, 10.1046/j.1471-4159.1997.69020594.x Zhang, 2005, Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease, FASEB J., 19, 533, 10.1096/fj.04-2751com Zhang, 2013, Human neuromelanin: an endogenous microglial activator for dopaminergic neuron death, Front. Biosci. (Elite Ed.), 5, 1